Loading...
MetaVia Inc.
MTVA•NASDAQ
Healthcare
Biotechnology
$1.28
$0.11(9.40%)
U.S. Market is Open • 13:42MetaVia Inc. (MTVA) AI-Powered Stock Analysis
See how MetaVia Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMetaVia Inc. (MTVA) Stock Overall Grade
MetaVia Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to MetaVia Inc.'s overall stock rating.
Forecast
C+Score
59/100Financial Growth
AScore
80/100Fundamental Growth
C+Score
55/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
B+Score
75/100MetaVia Inc. (MTVA) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 59/100 (C+), reflecting weak confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (55/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each MetaVia Inc. stock grade, including financials, comparisons, and forecasts.